Rekah Pharmaceutical total-risk-alpha technical analysis lookup allows you to check this and other technical indicators for Rekah Pharmaceutical Industry or any other equities. You can select from a set of available technical indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations and data normalization technicques. Please check also Equity Screeners to view more equity screening tools
Rekah
Rekah Pharmaceutical Industry has current Total Risk Alpha of 0.1752. The total risk alpha measures the performance of an asset by comparing its returns with those of a selected benchmark portfolio.
Total Risk Alpha
=
RFR + (ER[b] - ER[a])
x
STD[a] / STD[b]
=
0.1752
ER[a]
=
Expected return on investing in Rekah Pharmaceutical
ER[b]
=
Expected return on market index or selected benchmark
Rekah Pharmaceutical Total Risk Alpha Peers Comparison
Rekah Total Risk Alpha Relative To Other Indicators
Rekah Pharmaceutical Industry is rated fifth in total risk alpha category among its peers. It is currently under evaluation in maximum drawdown category among its peers reporting about 95.84 of Maximum Drawdown per Total Risk Alpha. The ratio of Maximum Drawdown to Total Risk Alpha for Rekah Pharmaceutical Industry is roughly 95.84
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.